DNA/RNA Synthesis Inhibitors

Cat.No. Product Name Information Product Use Citations Product Validations
S1166 Cisplatin Cisplatin is an inorganic platinum complex, which is able to inhibit DNA synthesis by conforming DNA adducts in tumor cells. Cisplatin activates ferroptosis and induces autophagy.Solutions are unstable and should be fresh-prepared.DMSO is not recommended to dissolve platinum-based drugs, which can easily lead to drug inactivation.
Cell, 2025, S0092-8674(25)00291-0
Cancer Cell, 2025, S1535-6108(25)00223-5
Cell Stem Cell, 2025, S1934-5909(25)00265-6
Verified customer review of Cisplatin
S1714 Gemcitabine Gemcitabine, a nucleic acid synthesis inhibitor, is a very potent and specific deoxycytidine analogue, used as chemotherapy. Gemcitabine induces a potent p53-dependent apoptosis.
Nature, 2025, 10.1038/s41586-025-08974-4
Cell, 2025, S0092-8674(25)00556-2
Cancer Cell, 2025, 43(8):1530-1548.e9
Verified customer review of Gemcitabine
S1209 5-Fluorouracil (5-FU) 5-FU (5-Fluorouracil) is a DNA/RNA synthesis inhibitor, which interrupts nucleotide synthetic by inhibiting thymidylate synthase (TS) in tumor cells. Fluorouracil induces apoptosis and can be used in the treatment of HIV.
Nature, 2025, 10.1038/s41586-025-08974-4
Cancer Cell, 2025, S1535-6108(25)00223-5
Cell Stem Cell, 2025, S1934-5909(25)00265-6
Verified customer review of 5-Fluorouracil (5-FU)
S1224 Oxaliplatin Oxaliplatin is a DNA alkylating agent that activates autophagy. Oxaliplatin inhibits DNA synthesis by conforming DNA adducts in RT4, TCCSUP, A2780, HT-29, U-373MG, U-87MG, SK-MEL-2, and HT-144 cells.Solutions are unstable and should be fresh-prepared.DMSO is not recommended to dissolve platinum-based drugs, which can easily lead to drug inactivation.
Nature, 2025, 10.1038/s41586-025-08974-4
Cancer Cell, 2025, S1535-6108(25)00223-5
Signal Transduct Target Ther, 2025, 10(1):341
Verified customer review of Oxaliplatin
S1149 Gemcitabine Hydrochloride Gemcitabine is a pyrimidine nucleoside analog antitumor drug that can inhibit DNA synthesis and repair, leading to cell autophagy and apoptosis. It is mainly used to treat various solid tumors such as pancreatic cancer and non-small cell lung cancer, and is often combined with chemotherapy to enhance efficacy.
Cancer Cell, 2025, S1535-6108(25)00271-5
Nat Cell Biol, 2025, 27(6):1021-1034
Trends Biotechnol, 2025, S0167-7799(25)00406-8
Verified customer review of Gemcitabine Hydrochloride
S1648 Cytarabine Cytarabine is an antimetabolic agent and DNA synthesis inhibitor with IC50 of 16 nM in wild-type CCRF-CEM cells. Cytarabine induces autophagy and apoptosis.
Nat Commun, 2025, 16(1):4133
Acta Pharm Sin B, 2025, 15(10):5277-5293
Cell Death Dis, 2025, 16(1):601
Verified customer review of Cytarabine
S2684 CX-5461 (Pidnarulex) CX-5461 (Pidnarulex) is an inhibitor of rRNA synthesis that selectively inhibits Pol I-driven transcription of rRNA with an IC50 of 142 nM in HCT-116, A375, and MIA PaCa-2 cells. It has no effect on Pol II and possesses 250- to 300-fold selectivity for inhibition of rRNA transcription versus DNA replication and protein translation.
Nat Commun, 2025, 16(1):2641
Nat Commun, 2025, 16(1):1676
Nucleic Acids Res, 2025, 53(18)gkaf939
Verified customer review of CX-5461 (Pidnarulex)
S1229 Fludarabine (NSC 118218) Phosphate Fludarabine Phosphate is an analogue of adenosine and deoxyadenosine, which is able to compete with dATP for incorporation into DNA and inhibit DNA synthesis.
Cell Death Differ, 2025, 10.1038/s41418-025-01585-6
J Autoimmun, 2024, 149:103307
Cell Death Dis, 2024, 15(3):224
Verified customer review of Fludarabine (NSC 118218) Phosphate
S1896 Hydroxyurea Hydroxyurea is an antineoplastic agent that inhibits DNA synthesis through the inhibition of ribonucleoside diphosphate reductase. Hydroxyurea activates apoptosis and autophagy. Hydroxyurea is used to treat HIV infection.
J Exp Med, 2025, 222(3)e20241248
Antimicrob Agents Chemother, 2025, e0047125.
Invest Ophthalmol Vis Sci, 2025, 66(5):42
Verified customer review of Hydroxyurea
S7742 SCR7 SCR7 is a specific DNA Ligase IV inhibitor, which blocks nonhomologous end-joining (NHEJ). It increases the efficiency of HDR-mediated genome editing up to 19-fold using CRISPR/Cas9 in mammalian cells and mouse embryos.
Mol Ther, 2025, S1525-0016(25)00650-1
bioRxiv, 2025, 2025.08.05.668752
Nucleic Acids Res, 2024, 52(22):13757-13774
Verified customer review of SCR7
S2794 Sofosbuvir Sofosbuvir is a HCV NS5B polymerase inhibitor for the treatment of chronic hepatitis C virus (HCV) infection.
Structure, 2025, S0969-2126(25)00193-5
J Med Virol, 2024, 96(7):e29787
PLoS One, 2024, 19(5):e0303265
Verified customer review of Sofosbuvir
S1156 Capecitabine Capecitabine is a tumor-selective fluoropyrimidine carbamate, which achieves higher intratumoral 5-FU level with lower toxicity than 5-FU. Capecitabine treatment of HCT-15 cells causes condensation of DNA and induces apoptosis.
Cell Stem Cell, 2025, S1934-5909(25)00265-6
Genes Dis, 2024, 11(1):430-448
iScience, 2024, 27(10):110862
Verified customer review of Capecitabine
S7975 Favipiravir (T-705) Favipiravir (T-705) is a potent and selective RNA-dependent RNA polymerase inhibitor, used to treat influenza virus infections.
PLoS Pathog, 2025, 21(8):e1013401
Front Pharmacol, 2025, 16:1491150
Vet World, 2025, 18(9):2785-2797
Verified customer review of Favipiravir (T-705)
S8246 RK-33 RK-33 is a first-in-class small molecule inhibitor of DDX3 (a RNA helicase) and causes G1 cell cycle arrest, induces apoptosis, and promotes radiation sensitization in DDX3-overexpressing cells.
Mol Cell, 2025, 85(3):585-601.e11
ASN Neuro, 2025, 17(1):2506406
J Immunol, 2025, vkaf281
S7718 BMH-21 BMH-21 is a DNA intercalator, which binds ribosomal DNA and inhibits RNA polymerase I (Pol I) transcription.
Nat Commun, 2025, 16(1):8018
Nucleic Acids Res, 2025, 53(15)gkaf766
Cell Death Discov, 2025, 11(1):282
Verified customer review of BMH-21
S5582 Cytarabine hydrochloride Cytarabine is a pyrimidine nucleoside analog that is used mainly in the treatment of leukemia. It is an antimetabolite antineoplastic agent that inhibits the synthesis of DNA.
Blood, 2022, blood.2022016090
Clin Transl Med, 2022, 12(2):e722
Front Pharmacol, 2022, 13:1032975
S7470 Triapine (3-AP) Triapine (3-AP) is a potent ribonucleotide reductase (RNR) inhibitor with broad spectrum antitumor activity by inhibiting DNA synthesis. Phase 2.
iScience, 2024, 27(10):110862
Cancer Cell, 2023, 41(5):933-949.e11
J Virol, 2023, 97(8):e0026723
Verified customer review of Triapine (3-AP)
S1289 Carmofur Carmofur (HCFU) is a highly potent acid ceramidase inhibitor, used in the treatment of breast and colorectal cancer.
iScience, 2024, 27(10):110862
JCI Insight, 2023, 8(9)e166850
Cell Death Discov, 2023, 9(1):451
S1217 Cyclophosphamide Cyclophosphamide(NSC 26271,Endoxan, Cytoxan, Neosar, Procytox, Revimmune, Cytophosphane) is a nitrogen mustard alkylating agent from the oxazophorines group.
Neurotherapeutics, 2025, 22(1):e00480
Sci Rep, 2025, 15(1):2893
Front Biosci (Landmark Ed), 2025, 30(11):45744
Verified customer review of Cyclophosphamide
S1213 Nelarabine Nelarabine (506U78,Arranon) is a purine nucleoside analog and DNA synthesis inhibitor with IC50 from 0.067-2.15 μM in tumor cells.
Communications Medicine, 2025, 420
iScience, 2024, 27(10):110862
Cancer Res, 2022, 82(4):721-733
Verified customer review of Nelarabine
S1305 Mercaptopurine (6-MP) Mercaptopurine (6-MP) is a widely used antileukemic agent and immunosuppressive drug that inhibits de novo purine synthesis through incorporation of thiopurine methyltransferase metabolites into DNA and RNA.
Cancer Cell, 2025, 43(4):776-796.e14
iScience, 2024, 27(10):110862
Nat Commun, 2023, 14(1):5913
S7679 YK-4-279 YK-4-279 is a potent inhibitor of EWS-FLI1 binding to RNA helicase A (RHA).
Nat Commun, 2024, 15(1):4590
Cancers (Basel), 2024, 16(21)3606
Cancers -Basel), 2023, 15(19)4772
Verified customer review of YK-4-279
S1299 Floxuridine (FUDR) Floxuridine (FUDR), a prodrug that is rapidly catabolized to 5-fluorouracil in vivo, is used to treat various cancers, particularly metastases to the liver. It inhibits Poly(ADP-Ribose) polymerase and induces DNA damage and apoptosis. This compound also has antiviral effects against HSV and CMV.
Toxicol Lett, 2025, 406:31-37
iScience, 2024, 27(10):110862
Cancer Cell, 2023, 41(5):933-949.e11
S4288 Chloroambucil Chloroambucil (Chlorambucil,CB-1348,WR-139013) is a nitrogen mustard alkylating agent, used in the treatment of chronic lymphocytic leukemia.
Cell Rep Med, 2024, 5(12):101834
iScience, 2024, 27(10):110862
Human Cell, 2024, 854-864
S1384 Mizoribine Mizoribine is an imidazole nucleoside and an immunosuppressant that inhibits HCV RNA replication with IC50 of ~ 100 μM for anti-HCV activity. This compound is a selective inhibitor of inosine-5'-monophosphate dehydrogenase (IMPDH) and guanosine monophosphate synthetase. It also inhibits SARS-CoV.
International Journal of Molecular Sciences, 2025, 11959
Biomolecules, 2025, 1425
Cancers, 2025, 3389
S1300 Tegafur (FT-207) Tegafur (NSC 148958,Fluorafur,FT-207) is a substance being used in the treatment of some types of cancer.
Lab Chip, 2024, 24(23):5251-5263
Lab on a Chip, 2024, 5251-5263
iScience, 2024, 27(10):110862
S8144 Halofuginone Halofuginone (RU-19110) is the competitively inhibitor of prolyl-tRNA synthetase with Ki of 18.3 nM.It could also down-regulate Smad3 and blocked TGF-β signaling at 10 ng/ml in mammal.
Sci Adv, 2025, 11(28):eadw1883
Cell Rep, 2024, 43(9):114728
J Neurochem, 2024, 10.1111/jnc.16102
S1995 Procarbazine HCl Procarbazine HCl (NSC-77213) is a hydrochloride salt form of procarbazine which is a polyfunctional alkylating compound, used for the treatment of Hodgkin's lymphoma.
iScience, 2024, 27(10):110862
J Pers Med, 2022, 12(2)258
Hum Cell, 2022, 10.1007/s13577-022-00671-y
S4227 Fidaxomicin Fidaxomicin is a narrow spectrum macrocyclic antibiotic that inhibits RNA polymerase sigma subunit.
J Antimicrob Chemother, 2024, dkae101
Nucleic Acids Res, 2023, 51(19):e99
bioRxiv, 2023, 2023.03.13.532464
S4239 Bergapten Bergapten is a psoralen that can be photoactivated and is capable of crossing-linking DNA, covalently modifying proteins and lipids, and consequently inhibiting cell replication.
J Pers Med, 2022, 12(2)258
Hum Cell, 2022, 10.1007/s13577-022-00671-y
Hum Cell, 2021, 10.1007/s13577-021-00579-z
S1516 Cidofovir Cidofovir suppresses virus replication by selective inhibition of viral DNA synthesis.
Oncol Lett, 2021, 21(4):280
Nat Biotechnol, 2019, 37(3):303-313
Antiviral Res, 2019, 162:178-185
Verified customer review of Cidofovir
S8850 JH-RE-06 JH-RE-06 is a potent REV1-REV7 interface inhibitor with an IC50 of 0.78 μM and Kd value of 0.42 μM, disrupting REV1-POL ζ-mediated mutagenic translesion synthesis (TLS).
Nat Commun, 2025, 16(1):1026
Nucleic Acids Res, 2024, gkae317
Nucleic Acids Res, 2024, gkae785
S4030 Gentamicin Sulfate Gentamycin Sulfate (NSC-82261, SCH9724) is a broad-spectrum, aminoglycoside antibiotic used for cell culture which inhibits protein synthesis in sensitive organisms.Gentamicin Sulfate can be used to induce animal models of Renal Failure.
Nat Commun, 2024, 15(1):6579
Pharmacol Res, 2024, 201:107096
bioRxiv, 2023, 10.1101/2023.08.03.551753
S7757 6-Thio-dG 6-thio-dG (β-TGdR) is a nucleoside analog and telomerase substrate.
Cell Death Discovery, 2024, 381
Cell Death Discov, 2024, 10(1):381
Radiation Medicine and Protection, 2022, 64-71
E1331 SU056 SU056 is an inhibitor of Y box binding protein 1 (YB-1) with IC50 of 1.73 μM in Sk0V3 cells.
bioRxiv, 2025, 2025.05.28.656712
bioRxiv, 2025, 2025.05.28.656712
Cancer Letters, 2024, 217197
S1760 Rifapentine Rifapentine (MDL473) is an antibiotic, which inhibits DNA-dependent RNA polymerase activity, used to treat tuberculosis.
International Journal of Molecular Sciences, 2022, 7383
Int J Mol Sci, 2022, 23(13)7383
Front Microbiol, 2020, 10:2936
S1826 Nedaplatin Nedaplatin (NSC 375101D) is a derivative of cisplatin and DNA damage agent for tumor colony forming units with IC50 of 94 μM.DMSO is not recommended to dissolve platinum-based drugs, which can easily lead to drug inactivation.
United Eur Gastroent, 2025, 13(7):1328-1342
iScience, 2024, 27(10):110862
Nat Commun, 2019, 10(1):5654
S4297 Mupirocin Mupirocin(BRL-4910A,Pseudomonic acid) is an isoleucyl t-RNA synthetase inhibitor, used in the treatment of bacterial skin infections.
Infect Drug Resist, 2023, 16:4867-4879
Anaerobe, 2020, 62:102169
Life Sci, 2019, 224:51-57
S1973 Cyclocytidine HCl Cyclocytidine (NSC 145668) is the prodrug of cytarabine, which is a pyrimidine nucleoside analog that inhibits the DNA synthesis and used mainly in the treatment of leukemia.
Transl Oncol, 2023, 35:101712
PeerJ, 2022, 10:e13719
Acta Biochim Biophys Sin (Shanghai), 2020, 14 pii: gmaa017
S7445 APX-3330 APX-3330 (E3330) is a potent and selective APE1(Ref-1) inhibitor, which suppressed NF-kappa B DNA-binding activity.
J Clin Invest, 2024, e183671
J Transl Med, 2023, 21(1):183
Cell Death Dis, 2022, 13(2):124
S3669 Carmustine Carmustine (bis-chloroethylnitrosourea, BCNU, BiCNU) is a cell-cycle phase nonspecific alkylating antineoplastic agent and used in the treatment of brain tumors and various other malignant neoplasms.
iScience, 2024, 27(10):110862
Nat Chem Biol, 2022, 10.1038/s41589-022-00996-7
Cancer Res, 2021, 81(23):6044-6057
S7546 Pritelivir (BAY 57-1293) Pritelivir (BAY 57-1293, AIC316) is a potent helicase primase inhibitor that exhibits antiviral effects on herpes simplex virus (HSV), with an IC50 of 20 nM for both HSV-1 and HSV-2.
bioRxiv, 2025, 2025.05.12.653380
Journal of Virology, 2024, e01836-24
PLoS Pathog, 2021, 17(11):e1010117
S1784 Vidarabine Vidarabine is an antiviral drug by interfering with the synthesis of viral DNA, used to treat herpes simplex and varicella zoster viruses.
Neuron, 2017, 96(6):1290-1302
ACS Appl Mater Interfaces, 2016, 8(39):25818-25824
Biogerontology, 2016, 17(5-6):907-920
S3001 Clevudine Clevudine(Levovir,L-FMAU) is an antiviral drug for the treatment of hepatitis B.
Cancer Research, 2024, 598-615
Journal of Biomedical Science, 2024, 34
J Biomed Sci, 2024, 31(1):34
E1070 Phen-DC3 Trifluoromethanesulfonate Phen-DC3 Trifluoromethanesulfonate is a G-quadruplex (G4) specific ligand which can inhibit FANCJ and DinG helicases with IC50s of 65 ± 6 and 50 ± 10 nM, respectively.
Nucleic Acids Res, 2025, 53(12)gkaf543
Nucleic Acids Research, 2025, gkaf732
Nucleic Acids Research, 2025, gkaf543
S0469 ML216 ML216 (CID-49852229) is a potent and selective inhibitor of the DNA unwinding activity of BLM(Bloom’s syndrome protein) with antitumor activity. This compound inhibits helicases with IC50 of 0.97 μM and 2.98 μM for BLM636-1298 and BLMfull-length, respectively.
Nature, 2024, 10.1038/s41586-024-08307-x
Elife, 2024, 13RP99026
Cells, 2022, 12(1)145
E2939 Didox Didox (3,4-dihydroxy-benzohydroxamic acid) is a synthetic ribonucleotide reductase (RR) inhibitor derived from polyhydroxy-substituted benzohydroxamic acid. This compound inhibits proliferation of resistant breast cancer cells.
Antimicrob Agents Chemother, 2025, e0047125.
Antimicrobial Agents and Chemotherapy, 2025, e00471-25
E1152 AGX51 AGX51, a first-in-class pan-Id (inhibitors of DNA-binding/differentiation proteins) antagonist and degrader, inhibits the Id1-E47 interaction, leading to ubiquitin-mediated degradation of Ids, cell growth arrest, and reduces viability, also inhibits pathologic ocular neovascularization.
bioRxiv, 2025, Preprint
bioRxiv, 2025, 2025.08.24.671623
S8095 Tubercidin Tubercidin (7-deaza-adenosine), an adenosine analogue, is a nucleoside antibiotic. It is incorporated into DNA and inhibits polymerases, thereby inhibiting DNA replication and RNA and protein synthesis. This agent also exhibits antifungal and antiviral activities.
Molecular Cell, 2020, 1104-1122.e9
Mol Cell, 2020, 80(6):1104-1122.e9
S0054 D-I03 D-I03 is a selective inhibitor of RAD52 with Kd of 25.8 µM. This compound inhibits ssDNA annealing by RAD52 and D-loop formation with IC50 of 5 µM and 8 µM, respectively.
NPJ Precis Oncol, 2025, 9(1):20
Biotechnology and Bioengineering, 2023, 2419-2440
S5484 Rimantadine Hydrochloride Rimantadine is an RNA synthesis inhibitor that is used as an antiviral agent in the prophylaxis and treatment of influenza. It works by inhibiting a viral protein called M2, which normally mediates the transport of acid ions across the influenza virion shell.
bioRxiv, 2020, 2020.08.12.246389
Journal of Virological Methods, 2019, 113714
S4504 6-Mercaptopurine (6-MP) Monohydrate 6-Mercaptopurine (6-MP) Monohydrate is a widely used antileukemic agent and immunosuppressive drug that inhibits de novo purine synthesis through incorporation of thiopurine methyltransferase metabolites into DNA and RNA.
Elife, 2025, 13RP102277
iScience, 2024, 27(10):110862
S7449 CRT0044876 CRT0044876 (NSC 69877, 7-NO2-ICA) is a potent and selective APE1 inhibitor with IC50 of ~3 μM.
Cell Rep, 2024, 43(10):114820
Nat Biotechnol, 2017, 35(5):463-474
S5293 Nimustine Hydrochloride Nimustine Hydrochloride (Nidran) is the hydrochloride salt of nimustine, a nitrosourea with antineoplastic activity that alkylates and crosslinks DNA, thereby causing DNA fragmentation, inhibition of protein synthesis, and cell death.
Biomed Pharmacother, 2023, 163:114751
Biomedicine & Pharmacotherapy, 2023, 114751
S3549 PFM01 PFM01, a cell-permeable N-alkylated Mirin derivative, is a selective inhibitor of MRE11 endonuclease activity.
Nucleic Acids Res, 2024, gkae903
Cell Rep, 2023, 42(7):112792
S2600 Fexinidazole Fexinidazole (HOE-239, Fexinidazole Winthrop) is a 5-nitroimidazole derivative. This compound is a DNA synthesis inhibitor and the only, all-oral agent for Human African Trypanosomiasis(HAT or sleeping sickness).
Sci Rep, 2025, 15(1):23579
Int J Mol Sci, 2024, 25(8)4413
S9718 TK216

TK216 is a potent inhibitor targeting E26 transformation specific (ETS) factors via blocking the protein-protein interaction with RNA helicases. This compound exhibits antilymphoma activity.

J Biol Chem, 2024, 300(6):107375
Sci Rep, 2023, 13(1):14360
S1790 Rifaximin Rifaximin is a RNA synthesis inhibitor by binding the β subunit of the bacterial DNA-dependent RNA polymerase, used to treat traveler's diarrhea caused by certain bacteria.
Int J Mol Sci, 2022, 23(13)7383
S5552 Amenamevir Amenamevir (ASP2151) is a potent helicase-primase inhibitor and a novel class of antiviral agent.
J Biomol Struct Dyn, 2020, 1-14
S0280 Madrasin Madrasin (DDD00107587) is a potent and cell-penetrant pre-mRNA splicing inhibitor. This compound interferes with the early stages of spliceosome assembly and stalls spliceosome assembly at the A complex.
Leukemia, 2023, 37(8):1649-1659
S9775 SCR130 SCR130 is a novel DNA repair inhibitor with IC50s of 14 μM in Reh cells and 2 μM in Nalm6 cells. This compound specifically inhibits DNA Ligase IV‐mediated joining with minimal or no effect on Ligase III and Ligase I mediated joining.
Sci Rep, 2025, 15(1):17871
E0488 BC-LI-0186 BC-LI-0186 is a selective blocker of Leucyl-tRNA synthetase (LRS, LeuRS) and Ras-related GTP-binding protein D (RagD) interaction (LRS-RagD interaction) (IC50 = 46.11 nM) by competing against RagD for LRS VC domain binding (KD = 42.1 nM), thereby inhibiting lysosomal localization of LRS and mTORC1 activity. This compound also effectively suppresses the activity of cancer-associated mTOR mutants and the growth of rapamycin-resistant cancer cells.
Cancer Res Treat, 2023, 55(3):851-864
S2961 GC7 Sulfate GC7 (N1-guanyl-1,7-diaminoheptane) Sulfate is an inhibitor of deoxyhypusine synthase (DHPS). GC7 inhibits Neuroblastoma (NB) cell proliferation in a dose-dependent manner, through induction of the cell cycle inhibitor p21 and reduction of total and phosphorylated Rb proteins.
Exp Mol Med, 2024, 10.1038/s12276-024-01214-1
E4581 Basic Orange 14 Basic Orange 14(Acridine Orange hemi (zinc chloride) salt) acts as an inhibitor of RNA polymerase which also functions as a cell-permeable metachromatic fluorescent dye that stains DNA and RNA.
S3009 Menthone

Menthone is one of the main volatile components of the essential oil of peppermint (Mentha piperita L.). This compound is used as antioxidant agent and has a good compensatory effect with significant reduction in DNA damages in sperm cells.

S3472 Metarrestin Metarrestin is an orally active and specific perinucleolar compartment (PNC) inhibitor that disrupts the nucleolar structure and inhibits RNA polymerase (Pol) I transcription. This compound blocks metastatic development and extends survival in mouse cancer models.
S8376 Rbin-1 Rbin-1 (Ribozinoindole-1) is a potent chemical inhibitor of eukaryotic ribosome assembly. It inhibits recombinant full-length Mdn1's ATPase activity in vitro.
E1596 AOH1996 AOH1996 is an orally active small-molecule PCNA inhibitor with potential anti-tumor activity. It enhances the interaction between PCNA and RPB1, the largest subunit of RNA polymerase II.
S0816 Brr2 Inhibitor C9 Brr2 inhibitor C9 (Brr2 Inhibitor 9) is an allosteric inhibitor of the spliceosomal RNA helicase Brr2. Brr2 is implicated in autosomal-dominant retinitis pigmentosa a group of progressive retinal degenerative disorders.
E8280New Ecubectedin Ecubectedin (PM14) is a transcriptional inhibitor that forms DNA adducts, blocking RNA synthesis and the transcription of protein-coding genes. It also exhibits potent antiproliferative activity in human solid cancer models both in vitro and in vivo.
E6712New PYCR1-IN-1 PYCR1-IN-1 (compound 4) is an inhibitor of pyrroline-5-carboxylate reductase 1 (PYCR1) with an IC50 of 8.8 µM. It significantly reduce the levels of proline within a breast cancer cell line and exhibits anti-cell proliferation effect.
S8328 CeMMEC1 HCl CeMMEC1 is an N-methylisoquinolinone derivative that inhibits the second bromodomain of TAF1 (IC50=0.9 μM).
E5836 ATX968 ATX968 (DHX9-IN-2) is a potent, selective, and orally bioavailable inhibitor of DHX9 helicase with an IC50 of 8 nM. It induces strong and sustained tumor growth inhibition or regression in MSI-H/dMMR colorectal cancer (CRC) xenograft models.
E6402New GSK4418959 GSK4418959 (IDE275) is a non-covalent, reversible, selective, and orally bioavailable WRN helicase inhibitor. It exhibits ATP-competitive inhibition of both ATPase activity and DNA unwinding function. This compound serves as a research tool for investigating microsatellite instability-high (MSI-H) cancers.
S0063 RG3039 RG3039 (PF-06687859, PF 6687859, Quinazoline 495) is an orally bioavailable and brain-penetrant inhibitor of the mRNA decapping enzyme DcpS with IC50 of 4.2 nM and IC90 of 40 nM, respectively.
S0780 Oncrasin-1 Oncrasin-1 (Onc-1) is a potent RNA polymerase II inhibitor with antitumor activity that kills various human lung cancer cells with K-Ras mutations. This compound drives abnormal aggregation of protein kinase C iota (PKCι) in nucleus of sensitive cells but not in resistant cells.
S9286 Neobavaisoflavone Neobavaisoflavone, isolated from seeds of Psoralea corylifolia, exhibits inhibitory activity against DNA polymerase and platelet aggregation.
E0443 LDC195943 (IMT1) LDC195943 (IMT1) is a specific and noncompetitive inhibitor of human mitochondrial RNA polymerase (POLRMT). This compound causes a conformational change of POLRMT, which blocks substrate binding and transcription in a dose-dependent way in vitro. It reduces deoxynucleoside triphosphate levels and citric acid cycle intermediates, resulting in a marked depletion of cellular amino acid levels. IMT1 has the potential for mitochondrial transcription disorders related diseases.
E0444 LDC203974 (IMT1B) LDC203974 (IMT1B) is an orally active, noncompetitive and specific allosteric inhibitor of mitochondrial RNA polymerase (POLRMT) that inhibits mitochondrial DNA (mtDNA) expression, and it has anti-tumour effects.
S7661New Aphidicolin Aphidicolin is a tetracyclic diterpenoid antibiotic produced by *Cephalosporium aphidicola* that specifically inhibits eukaryotic DNA polymerases α and δ, thereby blocking DNA replication and mitotic cell division. This compound demonstrates broad antiviral activity, including inhibition of herpes simplex virus replication and anti-orthopoxvirus effects. Additionally, this chemical enhances arabinosyl nucleoside-induced apoptosis in HL-60 human promyelocytic leukemia cells.
S9649 Acelarin (NUC-1031) Acelarin (NUC-1031, CPF-31, MTL-007, GTPL7389) is a DNA synthesis inhibitor with EC50 of 0.2 nM.
E1987 APX2009 APX2009 is a second-generation redox-specific inhibitor of APE1/Ref-1, an essential enzyme in the base excision repair (BER) pathway. This compound effectively reduces breast cancer cell proliferation and colony formation.
S0102 L 189 L 189 is a novel human DNA ligase inhibitor with IC50 of 5 μM, 9 μM and 5 μM for hLigI, hLigIII and hLigIV, respectively. This compound inhibits base excision repair (BER) and non-homologous end joining (NHEJ). It specifically sensitizes cancer cells to DNA damage.
S3641 Osalmid Osalmid suppresses ribonucleotide reductase (RNR) activity in a concentration-dependent manner, with a 50% RR activity-inhibitory concentration (IC50) of 8.23 μM.
S3360 Bis(2-ethylhexyl) phthalate

Bis(2-ethylhexyl) phthalate (Dioctyl phthalate, DOP, Diplast O, ESBO-D 82, Ergoplast FDO, Ergoplast FDO-S, Etalon) induces DNA strand breaks and gene expression alterations in larval zebrafish Danio rerio.

S5297 Vidarabine monohydrate Vidarabine (Spongoadenosine, Vira-A) is a nucleoside antibiotic with antiviral acitivity that interferes with the synthesis of viral DNA. It is used to treat herpes simplex and varicella zoster viruses.
E7688 L67 L67 (DNA Ligase Inhibitor) is a competitive inhibitor of DNA ligase that effectively targets both DNA ligases I and III, with an IC50 of 10 μM for both enzymes. It specifically disrupts mitochondrial DNA metabolism in cancer cells. Inhibition of DNA ligase IIIα (LigIIIα) by this compound leads to significant alterations in mitochondrial morphology, reduces mitochondrial DNA levels, and increases reactive oxygen species (ROS).
S1126 CX-3543(Quarfloxin) CX-3543 (Quarfloxin), a fluoroquinolone derivative, inhibits RNA pol I activity by disrupting the interaction between the nucleolin protein and a G-quadruplex DNA structure in the ribosomal DNA (rDNA) template.
S6115 Pyridoxal 5′-phosphate hydrate Pyridoxal 5′-phosphate (pyridoxal phosphate, Vitamin B6 phosphate, PAL-P, PLP), a vitamin B6 phosphate, is a coenzyme in a variety of enzymatic reactions. Pyridoxal 5′-phosphate at concentrations < 0.5 mM inhibits of polymerization deoxynucleoside triphosphate catalysed by variety of DNA polymerases isolated from type C RNA tumor viruses. The combination of Pyridoxal 5′-phosphate and NEIL2 will make NEIL2 completely lose its ability to bind damaged DNA.
E2921 Diethyl Pyrocarbonate Diethyl pyrocarbonate is a potent, non-specific inhibitor of RNase. It has been useful as an in vitro agent, relatively specific for binding to imidazole of histidine. It inhibits central chemosensitivity in rabbit and can modify Ser, Thr, His and Tyr residues.
S8977 BCH001 BCH001 is a specific PAPD5 inhibitor that restores telomerase activity and telomere length in dyskeratosis congenita (DC) patient induced pluripotent stem cells. This compound is a noncanonical poly(A) polymerase with an unusual RNA-binding motif.
E0510 Cidofovir hydrate Cidofovir hydrate is a selective inhibitor of viral DNA synthesis through the selective inhibition of viral DNA polymerase.
E6515New ML-60218 ML-60218 is a broad-spectrum inhibitor of RNA polymerase III (pol III), with an IC50 of 32 μM for Saccharomyces cerevisiae and 27 μM for human pol III. ML-60218 disrupts pre-assembled viroplasms and impedes the formation of new ones, acting independently of de novo transcription of cellular RNAs.
S4782 5-methoxyflavone 5-methoxyflavone is a novel DNA polymerase-beta inhibitor and neuroprotective agent against beta-amyloid toxicity.
E8200 Epirubicin Epirubicin (4'-epidoxorubicin) is a semisynthetic anthracycline derivative of doxorubicin that exerts its anti-tumor effect through binding to topoisomerase IIalpha (TOP2A) and inducing DNA double-strand breaks. It also acts as an inhibitor of Forkhead box protein p3 (Foxp3), reducing the immunosuppressive activity of regulatory T cells and enhancing anti-tumor immunity.
S4537 Oxolinic acid Oxolinic acid (Urinox, NSC 110364) is a quinolone antibiotic, inhibiting the enzyme DNA gyrase and DNA synthesis.It also acts as a dopamine reuptake inhibitor.
S8329 CeMMEC13 CeMMEC13 is an isoquinolinone that selectively inhibits the second bromodomain of TAF1 (IC50 = 2.1 µM).
E0511 Framycetin sulphate Framycetin sulfate (Neomycin B sulfate), an aminoglycoside antibiotic, is a potent RNase P cleavage activity inhibitor with a Ki of 35 μM, and competes for specific divalent metal ion binding sites in RNase P RNA, also inhibits hammerhead ribozyme with a Ki of 13.5 μM.
S7418 Cycloheximide Cycloheximide, an antifungal antibiotic, is an eukaryote protein synthesis inhibitor with IC50 of 532.5 nM and 2880 nM for protein synthesis and RNA synthesis in vivo, respectively. Cycloheximide suppresses ferroptosis and inhibits autophagy.Cycloheximide (NSC-185) can be used to induce animal models of Dysmnesia.Solutions are unstable and should be fresh-prepared.This product is a hazardous chemical (acute toxicity/flammable/skin corrosive). Please use it while wearing a protective face mask, gloves, and clothing.
Cancer Cell, 2025, S1535-6108(25)00070-4
Signal Transduct Target Ther, 2025, 10(1):81
Signal Transduct Target Ther, 2025, 10(1):26
S1491 Fludarabine Fludarabine is a STAT1 activation inhibitor which causes a specific depletion of STAT1 protein (and mRNA) but not of other STATs. Also a DNA synthesis inhibitor in vascular smooth muscle cells. Fludarabine induces apoptosis.
Cell Mol Immunol, 2025, 22(11):1478-1490
J Immunother Cancer, 2025, 13(7)e010926
Cell Rep, 2025, 44(4):115559
Verified customer review of Fludarabine
S1215 Carboplatin Carboplatin, a derivative of CDDP, is a DNA synthesis inhibitor which binds to DNA, inhibits replication and transcription and induces cell death and interfers with the cell's repair mechanism in A2780, SKOV-3, IGROV-1, and HX62 cells. It induces the formation of DNA interstrand crosslinks and DNA-protein crosslinks. Solutions are unstable and should be fresh-prepared.DMSO is not recommended to dissolve platinum-based drugs, which can easily lead to drug inactivation.
Nat Commun, 2025, 16(1):8932
Cell Rep Med, 2025, 6(6):102160
Cancer Res, 2025, 10.1158/0008-5472.CAN-24-2360
Verified customer review of Carboplatin
S8964 Actinomycin D (Dactinomycin) Actinomycin D (Dactinomycin, Act D, RASP-101) is a significant polypeptide antibiotic isolated from soil bacteria of the genus Streptomyces. Actinomycin D (Dactinomycin) inhibits DNA repair and rests the cell cycle at G1 phase with IC50 of 0.42 μM and 0.4 nM, respectively. Actinomycin D is an RNA and protein synthesis inhibitor that can suppress bacterial protein synthesis. Actinomycin D is an autophagy activator, induces p53-independent cell death and prolongs survival in high-risk chronic lymphocytic leukemia.This product is a hazardous chemical (acute toxicity/flammable/skin corrosive). Please use it while wearing a protective face mask, gloves, and clothing.
Signal Transduct Target Ther, 2025, 10(1):236
Mol Cancer, 2025, 24(1):217
Nat Plants, 2025, 11(11):2300-2318
S8146 Mitomycin C Mitomycin C (Ametycine) is an antineoplastic antibiotic by inhibiting DNA synthesis, used to treat different cancers. Mitomycin C induces apoptosis in a caspases-dependent and Fas/CD95-independent manner.This product is a hazardous chemical (acute toxicity/flammable/skin corrosive). Please use it while wearing a protective face mask, gloves, and clothing.
Cell, 2025, S0092-8674(25)00625-7
Biomaterials, 2025, 317:123090
EMBO J, 2025, 44(14):4013-4036
Verified customer review of Mitomycin C
S8932 GS-5734 (Remdesivir) Remdesivir (GS-5734), a monophosphoramidate prodrug of an adenosine analog, is an investigational broad-spectrum antiviral agent with in vitro activity against multiple RNA viruses, including Ebola and CoV.
J Microbiol Biotechnol, 2025, 35:e2411063
Chem Pharm Bull (Tokyo), 2025, 73(4):355-368
Phytomedicine, 2024, 136:156279
S1117 Triciribine (API-2) Triciribine (API-2) is a DNA synthesis inhibitor that also inhibits Akt in PC3 cell line and HIV-1 in CEM-SS, H9, H9IIIB, U1 cells with IC50 of 130 nM and 20 nM, respectively; it does not inhibit PI3K/PDK1 and is 5000-fold less active in cells lacking adenosine kinase. Phase 1/2.
Mol Psychiatry, 2025, 10.1038/s41380-025-02917-1
Transl Oncol, 2025, 58:102434
J Cell Sci, 2023, 136(4)jcs259788
Verified customer review of Triciribine (API-2)
S7409 Anisomycin (Flagecidin) Anisomycin (Flagecidin, Wuningmeisu C) is a bacterial antibiotic isolated from Streptomyces griseolus, which inhibits protein synthesis, and also act as a JNK activator. Anisomycin upregulates autophagy and increases apoptosis.
J Exp Med, 2025, 222(6)e20240272
Cell Rep Med, 2025, 6(2):101927
Theranostics, 2025, 15(10):4398-4415
Verified customer review of Anisomycin (Flagecidin)
S3035 Daunorubicin Hydrochloride (Daunomycin) Daunorubicin HCl inhibits both DNA and RNA synthesis and inhibits DNA synthesis with Ki of 0.02 μM in a cell-free assay. Daunorubicin is a topoisomerase II inhibitor that induces apoptosis.Daunorubicin (RP 13057) HCl can be used to induce animal models of Kidney Disease.
Nat Commun, 2025, 16(1):617
Cell Rep Med, 2025, 6(4):102053
Cell Rep Med, 2025, S2666-3791(25)00102-8
Verified customer review of Daunorubicin Hydrochloride (Daunomycin)
S1135 Pemetrexed Disodium (LY231514) Pemetrexed disodium is a novel antifolate and antimetabolite for TS, DHFR and GARFT with Ki of 1.3 nM, 7.2 nM and 65 nM in cell-free assays, respectively. Pemetrexed induces autophagy and apoptosis.
Nat Commun, 2025, 16(1):8932
Cell Death Dis, 2024, 15(8):555
Cell Commun Signal, 2024, 22(1):375
Verified customer review of Pemetrexed Disodium (LY231514)
S2239 Tubacin Tubacin is a highly potent and selective, reversible, cell-permeable HDAC6 inhibitor with an IC50 of 4 nM in a cell-free assay, approximately 350-fold selectivity over HDAC1. This compound reduces the replication of the Japanese Encephalitis Virus via the decrease of viral RNA synthesis.
Dev Cell, 2024, S1534-5807(24)00326-5
Cell Mol Life Sci, 2024, 82(1):32
bioRxiv, 2024, 2024.12.01.626286
Verified customer review of Tubacin
S5971 Pemetrexed Pemetrexed (LY231514) is a novel antifolate and antimetabolite for thymidylate synthase (TS), dihydrofolate reductase (DHFR) and glycinamide ribonucleotide formyltransferase (GARFT) with Ki of 1.3 nM, 7.2 nM and 65 nM in cell-free assays, respectively. This compound induces autophagy and apoptosis.
Nat Commun, 2025, 16(1):7853
Nat Commun, 2025, 16(1):8476
Sci Adv, 2025, 11(4):eadp4765
S7419 Blasticidin S Hydrochloride Blasticidin S HCl is a nucleoside antibiotic isolated from Stretomyces girseochromogenes. It acts by blocking hydrolysis of peptidyl-tRNA induced by release factors and inhibits peptide bond formation. It is used to select transfected cells carrying bsr or BSD resistance genes.
Nat Commun, 2025, 16(1):3756
Sci Rep, 2025, 15(1):35610
RSC Chem Biol, 2025, 6(6):919-932
S1199 Cladribine Cladribine is an adenosine deaminase inhibitor for U266, RPMI8226, and MM1.S cells with IC50 of approximately 2.43 μM, 0.75 μM, and 0.18 μM, respectively.
Nature, 2025, 10.1038/s41586-025-08585-z
Nat Commun, 2024, 15(1):9820
iScience, 2024, 27(10):110862
S1373 Daptomycin Daptomycin is a novel antibiotic with rapid in vitro bactericidal activity against gram-positive organisms.
Molecules, 2023, 28(2)621
Infect Drug Resist, 2023, 16:4867-4879
Microbiol Spectr, 2023, e0092023.
Verified customer review of Daptomycin
S1218 Clofarabine Clofarabine (Clolar) inhibits the enzymatic activities of ribonucleotide reductase (RNR) (IC50 = 65 nM) and DNA polymerase. Clofarabine induces autophagy and apoptosis.
Invest Ophthalmol Vis Sci, 2025, 66(5):42
bioRxiv, 2025, 2025.04.25.650475
iScience, 2024, 27(10):110862
Verified customer review of Clofarabine
S8434 RAD51 Inhibitor B02 B02 is a small-molecule inhibitor of human RAD51 with an IC50 of 27.4 μM, but does not inhibit its E. coli homologue RecA (IC50 > 250 μM).
Nucleic Acids Res, 2025, 53(18)gkaf961
NPJ Precis Oncol, 2025, 9(1):20
Clin Epigenetics, 2025, 17(1):20
Verified customer review of RAD51 Inhibitor B02
S1302 Ifosfamide Ifosfamide is a nitrogen mustard alkylating agent used in the treatment of cancer.
iScience, 2024, 27(10):110862
Cancers (Basel), 2024, 16(21)3565
Cancer Res, 2023, 83(16):2750-2762
Verified customer review of Ifosfamide
S1807 Acyclovir (Aciclovir) Acyclovir (Aciclovir) is a synthetic nucleoside analogue active against herpesviruses, and it induces cell cycle perturbation and apoptosis in Jurkat leukemia cells.
Int J Mol Sci, 2025, 26(15)7185
Virol Sin, 2025, S1995-820X(25)00102-6
Nat Commun, 2024, 15(1):9461
Verified customer review of Acyclovir (Aciclovir)
S1221 Dacarbazine Dacarbazine is a triazene derivative with antineoplastic activity. This compound alkylates and cross-links DNA during all phases of the cell cycle, resulting in disruption of DNA function, cell cycle arrest, and apoptosis; it is used in the treatment of various cancers.
Nat Commun, 2025, 16(1):512
J Nanobiotechnology, 2025, 23(1):411
Sci Rep, 2025, 15(1):35889
S1192 Raltitrexed Raltitrexed (ZD-1694) is a thymidylate synthase inhibitor with an IC50 of 9 nM for the inhibition of L1210 cell growth.
iScience, 2024, 27(10):110862
Mol Ther, 2022, S1525-0016(22)00717-1
ACS Chem Neurosci, 2022, 13(17):2646-2657
Verified customer review of Raltitrexed
S1764 Rifampin (Rifampicin) Rifampin (Rifampicin) is a DNA-dependent RNA polymerase inhibitor and is used to treat a number of bacterial infections.
Pharmaceutics, 2024, 16(10)1290
ACS Infect Dis, 2024, 10(12):4087-4102
Discov Oncol, 2024, 15(1):709
S2678 NSC 207895 NSC 207895 (XI-006) suppresses MDMX with IC50 of 2.5 μM, leading to enhanced p53 stabilization/activation and DNA damage, and also regulates MDM2, an E3 ligase.
PLoS One, 2024, e0295629
PLoS One, 2024, 19(1):e0295629
Front Oncol, 2021, 11:582511
Verified customer review of NSC 207895
S1949 Menadione (Vitamin K3) A fat-soluble compound, Menadione (Vitamin K3) is an inhibitor of Cdc25 phosphatase and mitochondrial DNA polymerase γ (pol γ), used as a nutritional supplement.
mSphere, 2025, 10(1):e0070324
Med -N Y, 2022, S2666-6340-2200365-8
Mol Cell, 2021, S1097-2765(21)00269-0
S1778 Trifluridine (NSC 75520) Trifluridine (NSC 75520), also known as NSC 529182, Viroptic, Trifluorothymidine, or TFT, is an anti-herpesvirus antiviral agent that acts by interfering with viral DNA replication and is used primarily on the eye.
Nat Med, 2023, 29(3):605-614
JCI Insight, 2022, 7(22e158060)
Biochem Biophys Res Commun, 2022, 610:119-126
S5948 Amodiaquine Amodiaquine is a synthetic aminoquinoline that acts by binding to the protozoal or parasitic DNA and preventing DNA and RNA production and subsequent protein synthesis. It is used for the therapy of malaria.
Cell Death Discov, 2024, 10(1):434
Molecules, 2024, 29(6)1363
Nat Biomed Eng, 2021, 10.1038/s41551-021-00718-9
S8539 TAS-102 (Trifluridine/Tipiracil Hydrochloride Mixture) TAS-102 (Trifluridine-Tipiracil Hydrochloride Mixture) is an orally administered combination of a thymidine-based nucleic acid analogue, trifluridine, and a thymidine phosphorylase inhibitor, tipiracil hydrochloride.
Cell Death Dis, 2025, 16(1):255
iScience, 2024, 27(10):110862
STAR Protoc, 2024, 5(2):103090
S1907 Metronidazole Metronidazole, a synthetic antibacterial and antiprotozoal agent of the nitroimidazole class, is used against protozoa.
Dis Model Mech, 2024, 17(10)dmm050900
Microorganisms, 2022, 10(7)1421
Elife, 2021, 10e69795
S9936 ART558 ART558 is a potent, selective, low molecular weight, allosteric inhibitor of DNA Polθ with an IC50 of 7.9 nM.
Cancer Discovery, 2025, 69-82
Leukemia, 2025, 2152-2162
Leukemia, 2025, 39(9):2152-2162
S9521 Pentostatin Pentostatin(CI-825,Deoxycoformycin) is a potent inhibitor of adenosine deaminase. The drug is effective in the treatment of many lymphoproliferative malignancies, particularly hairy-cell leukemia. It is also synergistic with some other antineoplastic agents and has immunosuppressive activity.
Nat Metab, 2023, 5(10):1820-1835
Res Sq, 2023, rs.3.rs-2276903
Nat Metab, 2020, 10.1038/s42255-020-0227-4
S5953 Menadione bisulfite sodium Menadione(Vitamin K3) bisulfite sodium, a fat-soluble compound, is an inhibitor of Cdc25 phosphatase and mitochondrial DNA polymerase γ (pol γ), used as a nutritional supplement.
J Adv Res, 2025, S2090-1232(25)00065-7
Life Sci, 2020, 242:117159
Life Sciences, 2020, 117159
E1528 RP-6685 RP-6685 is a potent, selective, and orally active inhibitor of DNA polymerase theta (Polθ). RP-6685 exhibits antitumor efficacy in animal models.
Leukemia, 2025, 2152-2162
Leukemia, 2025, 39(9):2152-2162
S8942 Suramin sodium salt Suramin sodium salt (Suramin hexasodium salt) is a reversible and competitive protein-tyrosine phosphatase (PTPases) inhibitor, also is the potent inhibitor of sirtuins, purified topoisomerase II and SARS-CoV-2 RNA-dependent RNA polymerase (RdRp).
Biol Pharm Bull, 2025, 48(5):657-671
J Biol Chem, 2024, S0021-9258(24)00128-5
S4737 Psoralen Psoralen (Psoralene, Ficusin, Furocoumarin) is a naturally occurring furocoumarin that intercalates with DNA, inhibiting DNA synthesis and cell division.
Metabolites, 2022, 13(1)3
Metabolites, 2022, 3
S7637 DTP3 DTP3 is a selective GADD45β/MKK7 (growth arrest and DNA-damage-inducible β/mitogen-activated protein kinase kinase 7) inhibitor and is able to restore MKK7/JNK activation. This compound inhibits cancer-selective NF-κB survival pathway.
Life Sci Alliance, 2024, 7(8)e202302555
MedComm (2020), 2023, 4(3):e269
S5813 Isoginkgetin Isoginkgetin is a naturally derived biflavonoid with anti-tumor activity. This compound directly inhibits the chymotrypsin-like, trypsin-like, and caspase-like activities of the 20S proteasome. It also is a general inhibitor of Pre-mRNA splicing.
Cell Death Dis, 2024, 15(4):289
S3168 cis-Resveratrol cis-Resveratrol (cis-RESV, cRes, (Z)-Resveratrol) is the Cis isomer of Resveratrol. Resveratrol is a natural phenolic compound with anti-oxidant, anti-inflammatory, cardioprotective, and anti-cancer properties. Resveratrol is an inhibitor of pregnane X receptor (PXR) and an activator of Nrf2 and SIRT1 and may induce apoptosis. Resveratrol also inhibits a wide spectrum of targets including 5-lipoxygenase (LOX), cyclooxygenase (COX), IKKβ, DNA polymerases α and δ with IC50 of 2.7 μM, <1 μM, 1 μM, 3.3 μM and 5 μM, respectively.
J Gerontol A Biol Sci Med Sci, 2022, 77-8:1485-1493
S6848 3'-Fluoro-3'-deoxythymidine (Alovudine) 3'-Fluoro-3'-deoxythymidine (Alovudine, CL 184824, FddThd, FLT, MIV-310) is a potent inhibitor of polymerase γ and reverse transcriptase that can be used in the treatment of HIV infection. It is also a marker of DNA synthesis that can be used as an early response biomarker in the chemotherapy of pancreatic cancer.
Toxicol Lett, 2025, 406:31-37
S6854 Triazavirin (TZV) Triazavirin (TZV) is a novel antiviral drug, a nucleoside analogue of nucleic acid that inhibits the synthesis of viral RNA and DNA and replication of genomic fragments. It is active against influenza and a number of other viruses, and is an effective protective agent on the transmission stage of influenza.
Nature, 2022, 604(7904):120-126
E0459 Robinetin Robinetin inhibits HIV integrase cleavage and integration in a dose-dependent manne, inhibits the DNA synthesis in Proteus vulgaris, and the RNA synthesis in S. aureus, also inhibits egg yolk phosphatidylcholine (EYPC) membrane lipid peroxidation and hemoglobin A (HbA) glycosylation with high efficiency.
E1111 VV116 VV116, a promising orally administered anti-SARS-CoV-2 nucleoside drug candidate, exerts functions by targeting the viral RNA-dependent RNA polymerase through its nucleoside triphosphate form with an IC50 of 0.67±0.24 μM.
S3356 Phosphonoacetic acid

Phosphonoacetic acid (PAA) is an active endogenous metabolite that possesses a restricted potential to block DNA biosynthesis. This compound exhibits anti-viral activities.

S0161 ML367 ML367 is a potent, micromolar inhibitor of ATPase family AAA domain-containing protein 5 (ATAD5) stabilization. This compound blocks DNA repair pathways and general DNA damage responses including RPA32-phosphorylation and CHK1-phosphorylation in response to UV irradiation.
E1529 ART812 ART812 is an orally active DNA polymerase Polθ inhibitor with an IC50 value of 7.6 nM.
S4236 Proflavine Hemisulfate Proflavine Hemisulfate is a topical antiseptic by interchelating DNA, thereby disrupting DNA synthesis and leading to high levels of mutation in the copied DNA strands.
E6541New PolQi2 PolQi2 is a PolΘ inhibitor that specifically targets the N-terminal helicase domain of PolΘ, thereby suppressing alt-EJ (alternative end-joining) repair. This compound improves the accuracy and integration efficiency of gene editing across multiple loci and diverse cell lines. Additionally, PolQi2 demonstrates synergistic effects with DNA-PK inhibitors in reducing Cas9-mediated off-target activity. Its application is suitable for gene editing studies.
S2427 Triglycidyl Isocyanurate (Teroxirone) Triglycidyl Isocyanurate (Teroxirone, Tris(2,3-epoxypropyl) Isocyanurate, TGI, TGIC) is a triazene triepoxide with antineoplastic activity. It inhibits growth of human non-small cell lung cancer cells by activating p53. This compound alkylates and cross-links DNA, thereby inhibiting DNA replication. It is also used in various polyester powder coatings in the metal finishing industry.
E1939 ART899 ART899, a derivative of ART558 is a potent, specific allosteric inhibitor of DNA polymerase theta (Polθ), specifically inhibits Polθ MMEJ activity with IC50 of 180 nM. It specifically radiosensitizes tumor cells and have a potent stand-alone antitumor effect in cancer cells.